{"disease":{"id":"anti-il-6r","name":"anti il 6r"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06726096","title":"Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":615,"lead_sponsor_name":"Beijing VDJBio Co., LTD.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}